Yükleniyor

Yayın ve Akademik Faaliyet Özeti

35
Makale
354
Atıf
9
Bildiri
İndekslere Göre Yayın Sayıları
5 indeks
43
SCI-E
3
TR Dizin
2
ESCI
1
SSCI
1
SCOPUS
Makale Bilgileri
1
2
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy, IN VIVO, 40(1), 2026 SCI / SCI EXPANDED
Ece Duygu Gülşen, Araş.Gör.Dr. Rashad Ismayılov, Uzm.Dr. Aydan Farzalıyeva, Mehmet Nezir Ramazanoğlu, Prof. Dr. Arzu Oğuz
3
4
Real-world outcomes of trastuzumab deruxtecan in patients with HER2+ metastatic breast cancer: Turkish oncology group multicenter study, Therapeutic Advances in Medical Oncology, 18(0), 2026 SCI / SCI EXPANDED
Taha Koray Sahin, Fatih Kemik, Harun Muglu, Bedriye Acikgöz Yildiz, Sedat Biter
5
Prognostic Value of Liver Function-based Scores in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation, IN VIVO, 40(4), 2026 SCI / SCI EXPANDED
Uzm.Dr. Aydan Farzalıyeva, Mehmet Nezir Ramazanoğlu, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçalı, Prof. Dr. Özden Altundağ
6
Automated extraction of key entities from non-english thorax CT reports using machine learning by large context, many-shot Generative AI, BMC Medical Informatics and Decision Making, 2026(0), 2026 SCI / SCI EXPANDED
Prof. Dr. Zafer Akçalı, Doç. Dr. Murat Koçak, Uzm.Dr. Aydan Farzalıyeva, Araş.Gör.Dr. Fatih Güven, Mehmet Nezir Ramazanoğlu
7
The use of generative AI tools among individuals with cancer and their caregivers: a cross-sectional study of awareness, attitudes, and experiences, SUPPORTIVE CARE IN CANCER, 34(10), 2026 SCI / SCI EXPANDED
Araş.Gör.Dr. Rashad Ismayılov, Prof. Dr. Arzu Oğuz, Araş.Gör.Dr. Gizem Yılmaz Zenger, Şerife Merve Bölük, Uzm.Dr. Aydan Farzalıyeva
8
9
10
11
12
13
Artificial Intelligence for Immunotherapy Response Assessment in Lung Cancer Using PET/CT Reports, Japanese Journal of Radiology, 43(12), 2025 SCI / SCI EXPANDED
Araş.Gör.Dr. Rashad Ismayılov, Prof. Dr. Özden Altundağ, Prof. Dr. Esra Arzu Gençoğlu, Prof. Dr. Ayşe Aktaş, Sila Alparslan
14
15
Posttransplant Malignancies in Adult Transplant Patients, Experimental and Clinical Transplantation, 23(11), 2025 SCI / SCI EXPANDED
Mehmet Nezir Ramazanoğlu, Uzm.Dr. Aydan Farzalıyeva, Doç. Dr. Emre Karakaya, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçalı
16
17
Automated Extraction of Key Entities from Non-English Mammography Reports Using Named Entity Recognition with Prompt Engineering, Bioengineering-Basel, 12(2), 2025 SCI / SCI EXPANDED
Prof. Dr. Zafer Akçali, Öğr.Gör. Hazal Selvi Çubuk, Prof. Dr. Arzu Oğuz, Öğr.Gör. Murat Koçak, Araş.Gör.Dr. Aydan Farzaliyeva
18
Use of Immune Checkpoint Inhibitors in Solid-Organ Transplant Patients: An Orphan Issue, Experimental and Clinical Transplantation, 23(11), 2025 SCI / SCI EXPANDED
Efe Hasdemir, Uzm.Dr. Aydan Farzalıyeva, Mehmet Nezir Ramazanoğlu, Prof. Dr. Zafer Akçalı, Prof. Dr. Özden Altundağ
19
20
21
Is Tamoxifen Use a Factor Affecting Continence in Breast Cancer Patients?, Cureus, 11(8), 2020 SCOPUS
Prof. Dr. Arzu Oğuz, Gökşen İnanş İmamoğlu, Tülay Eren, Nuriye Yıldırım, Cengiz Karaçin
22
23
The impact of lymph node ratio on overall survival in patients with colorectal cancer, Journal of Cancer Research and Therapeutics, 8(0), 2020 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Gökşen İnanç İmamoğlu, Sanem Çimen, Tülay Eren, Cengiz Karaçin
24
25
26
27
Dosetaxel Induced Pericardial Effusion in Two Gastric Cancer Patients, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 26(2), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Doğan Yazılıtaş, Dilşen Çolak, İnanç İmamoğlu, Mustafa Altınbaş
28
Extracorporeal Shock Wave Therapy for Breast Cancer?Related Lymphedema: A Pilot Study, ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 97(9), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu
29
Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?, Cancer Research and Treatment, 48(1), 2016 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu
30
31
32
Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients., JOURNAL OF CLINICAL ONCOLOGY, 32(0), 2014 SCI / SCI EXPANDED
Doğan Uncu, İbrahim Varoğlu, Ülkü Yalçıntaş, Mehmet Küçüköner, Mehmet Artaç
33
Hepatitis B and C Seroprevalence in Solid Tumors - Necessity for Screening During Chemotherapy, Asian Pacific Journal of Cancer Prevention, 15(3), 2014 SCI / SCI EXPANDED
Prof. Dr. Arzu Oğuz, Fatma Aykaş, Dilek Ünal, Samet Karahan, Emine Uslu
34
Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival?, PATHOLOGY RESEARCH AND PRACTICE, 209(12), 2013 SSCI
Prof. Dr. Arzu Oğuz, Dilek Ünal, Arzu Taşdemir, Cellalettin Eroğlu, Yasemin Cihan
35
1
The use of generative AI tools by cancer patients and caregivers: A cross-sectional survey of awareness, attitudes, and experiences
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) · 01.06.2026
Araş.Gör.Dr. Rashad Ismayılov, Prof. Dr. Arzu Oğuz, Araş.Gör.Dr. Gizem Yılmaz Zenger, Şerife Merve Bölük, Araş.Gör.Dr. Aydan Farzaliyeva
2
Large language model-assisted decision-making in multidisciplinary tumor boards for colorectal cancer
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) · 29.05.2026
Araş.Gör.Dr. Aydan Farzaliyeva, Prof. Dr. Arzu Oğuz, Prof. Dr. Özden Altundağ, Prof. Dr. Zafer Akçali
3
Large language models as decision support in the absence of genomic profiling: A simulated prospective study on early-stage breast cancer
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) · 29.05.2026
Araş.Gör.Dr. Rashad Ismayılov, Prof. Dr. Arzu Oğuz, Kadri Altundağ, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ
4
Posttransplant malignancies in adult transplant patients: A single center experience
30th International Congress of The Transplantation-Society (TTS) · 22.09.2024
Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Doç. Dr. Samed Rahatlı
5
Recurrence of hepatocellular carcinoma after liver transplantation: A single-center experience
30th International Congress of The Transplantation-Society (TTS) · 22.09.2024
Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Prof. Dr. Arzu Oğuz
6
Automated Extraction of Key Entities from Thorax CT Reports Using NER with Prompt Engineering
2024 World Conference on Lung Cancer · 08.09.2024
Prof. Dr. Zafer Akçali, Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Fatih Güven, Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Uzm. Dr. Efe Hasdemir
7
Meme Kanseriyle Birlikte Görülen Tiroid Kanserinin Osteoporoz Gelişimi İle İlişkisi
45. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2024 · 19.04.2024
Araş.Gör.Dr. Ece Gül Köse Hamidi, Arş.Gör.Dr.Enes Arslanoğlu, Araş.Gör.Dr. Deniz Türküm Atikcan Şimşek, Prof. Dr. Özlem Turhan İyidir, Prof. Dr. Asli Nar
8
Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients
ASCO · 12.05.2016
Gül Sema Keskin, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ
9
Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes.
american society of clinical oncology (ASCO) · 30.05.2014
Taner Babacan, Prof. Dr. Arzu Oğuz, Prof. Dr. Özden Altundağ
↑